Viral Vectors and Plasmid DNA Manufacturing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Plasmid DNA Manufacturing Companies and the Market is Segmented by Product Type (Plasmid DNA, Viral Vector, and Non-viral Vector), Application (Cancer, Genetic Disorder, Infectious Disease, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America).

Viral Vectors and Plasmid DNA Manufacturing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Viral Vector & Plasmid DNA Manufacturing Industry Overview

The market is still in the nascent stage. Hence, increasing focus is mainly on the development of innovative products. Key market players include Cobra Biologics, Fujifilm Diosynth Biotechnologies, SIRION Biotech, Merck KGaA Inc., and Thermo Fisher Scientific.

Various strategies, such as research and development, mergers and acquisitions, and product launches, are being adopted by domestic companies to strengthen their market position. In December 2020, CHA Biotech signed a lease agreement with Matica Bio to construct a viral vector production facility in College Station, Texas. The construction of the 25,000 sq. ft facility started in Q4 2020. It is expected to be dedicated to producing viral vectors used in cell and gene therapies, vaccines, and oncolytic products. It was scheduled to open in Q3 2021.

Viral Vector & Plasmid DNA Manufacturing Market Leaders

  1. Fujifilm Diosynth Biotechnologies

  2. SIRION Biotech

  3. Thermo Fisher Scientific

  4. Merck KGaA Inc.

  5. Cognate BioServices Inc. (Cobra Biologics)​

  6. *Disclaimer: Major Players sorted in no particular order
Viral Vector and Plasmid DNA Manufacturing Market Concentration

Viral Vectors and Plasmid DNA Manufacturing Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?